Bormioli Pharma
Silvio Perri is an experienced HR professional currently serving as an HR Business Partner & People Development at Bormioli Pharma since October 2019, where responsibilities include managing talent acquisition, training and development, talent management, compensation and benefits, and labor relations for the headquarters population. Prior to this role, Silvio Perri worked as an HR Generalist at Davines from September 2018 to August 2019 and completed an internship focused on training needs assessment, recruitment, onboarding, and organizational communications. Educational credentials include a Laurea Specialistica in Relazioni di Lavoro from the Università degli Studi di Modena e Reggio Emilia, a Laurea Triennale in Scienze del Servizio Sociale from the Università degli Studi di Parma, and a diploma in Fisica teorica e matematica from Liceo Scientifico. Recent professional development activities include training programs at Scuola di Formazione IPSOA in 2023.
This person is not in any offices
Bormioli Pharma
Established in 1825, Bormioli Pharma is a leading Italian pharma primary packaging manufacturer. Bormioli Pharma works closely with the pharmaceutical industry and all companies that are working towards the future of healthcare globally. As a world-renowned player in the packaging industry, the company serves the pharmaceutical and biopharmaceutical markets with complete solutions, including glass and plastic bottles, plastic and aluminum closures and accessories. Bormioli Pharma’s wide product ranges are designed and manufactured looking forward innovation and addressing ever-growing sustainability issues. Moreover, each product is specifically conceived for the destination market thanks to an accurate portfolio segmentation. Bormioli Pharma has a global presence in over 100 countries, with more than 1,400 employees and 9 plants across Europe specialized in the production of glass and plastic packaging. Each year, the company produces more than 7 billion pieces and in 2022 reported annual sales of approximately 315 million euros. As a partner to the pharmaceutical industry, Bormioli Pharma invests and innovates with one goal in mind: making health a positive practice, available to everyone, kind to the planet.